Osobní účet
Osobní účet
Kymera Therapeutics
Biotechnology company that specializes in the field of targeted protein degradation
Rok založení
2017
Uzávěrka
8/27/2020
Ziskovost
60.55%
O společnosti
Total Funding
$454M
Kymera Therapeutics is a biotechnology company that specializes in the field of targeted protein degradation. It features a proprietary predictive modeling degradation platform with a novel small molecule modality to accelerate the drug discovery designed for disease-causing proteins.
Number of employees
100 - 250
Headquarters
Cambridge, Massachusetts, United States